Wiskind assists Moscow R-Pharm to build Covid-19 Vaccine Plant

Moscow-based "R-Pharm" will become a leading manufacturer of Russia's Sputnik V covid-19 vaccine.

On December 11, 2020, Moscow Mayor Sergei Sobyanin and R-Pharm Chairman Alexey Repik checked the progress of the production of the vaccine against Covid-19 in the Moscow plant. The project is being developed by R-Pharm. Wiskind provided more than 40,000 square meters of rock wool cleanroom panels, cleanroom doors and other cleanroom enclosure products for the project.

The production base will produce the flagship home vaccine "Sputnik V" developed by the Epidemiology and Microbiology Center. According to this project, when the factory reaches full capacity, it will produce up to 20 million doses of vaccine every month. The total investment in the project amounts to 8.6 billion rubles. The R-Pharm enterprise plans to start at the end of December 2020, and the first batch of Sputnik V vaccines are planned to be produced in Moscow Technopolis in January 2021. The construction of the complex located on the territory of the special economic zone "Technopolis "Moscow" took place in record time, which is necessary for the implementation of national and urban vaccination programs. The area of the new factory will exceed 20,000 square meters.